Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Elevated plasma anandamide levels in sclerotic chronic graft-versus-host disease highlight the endocannabinoid system as a potential therapeutic target.
Journal: Bone marrow transplantation
Published: June 24, 2026
Toward Better Response Assessment of Cutaneous Chronic Graft-Versus-Host Disease: A Report from the National Institutes of Health Consensus Project Task Force.
Journal: Transplantation and cellular therapy
Published: November 14, 2025
Cellular Therapy for Systemic Autoimmune Diseases: New Opportunities for Future Research and Interdisciplinary Collaboration.
Journal: ACR open rheumatology
Published: June 03, 2025
Prevalence of clonal hematopoiesis of indeterminate potential in patients with severe chronic graft-versus-host disease.
Journal: Bone marrow transplantation
Published: December 02, 2024
Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus.
Journal: Rheumatology (Oxford, England)
Published: October 02, 2021
Correction: Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study.
Journal: Bone marrow transplantation
Published: May 11, 2021
Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease.
Journal: Bone marrow transplantation
Published: October 12, 2020
Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study.
Journal: Bone marrow transplantation
Published: August 01, 2020
Clinical characteristics and cytokine biomarkers in patients with chronic graft-vs-host disease persisting seven or more years after diagnosis.
Journal: American journal of hematology
Published: September 24, 2019
Achalasia in a Patient Undergoing Hematologic Stem Cell Transplant After Exposure to Tacrolimus.
Journal: Mayo Clinic proceedings. Innovations, quality & outcomes
Published: September 19, 2018
Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogramming.
Journal: Nature chemical biology
Published: August 08, 2018
Last Updated: 09/26/2026